ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Today, Nexus Pharmaceuticals announced the launch of Baclofen Injection, USP. This sterile solution is designed for intrathecal administration and serves as a ...

On the heels of FDA approval of its new anti-spasticity drug Gablofen, CNS Therapeutics has raised $3 million in equity, according to documents filed with the Securities and Exchange Commission.

Medtronic plcMDT announced study results showing the superiority of Medtronic ITB (Intrathecal baclofen) Therapy to conventional medical management (CMM) for the reduction of severe post-stroke ...

Study design: Case report of Baclofen pump catheter failure investigated by radioisotope injection. Objectives: To report a safe and reliable method for evaluating catheter dysfunction. Setting: ...